BillionToOne, Inc. Class A Common Stock vs. Castle Biosciences, Inc. Common Stock
BLLN
BillionToOne, Inc. Class A Common Stock
$105.92 -4.29%
VS CSTLCastle Biosciences, Inc. Common Stock
$35.75 -2.80%
BillionToOne, Inc. Class A Common Stock (BLLN) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BLLN | CSTL | |
|---|---|---|
| Market Cap | $5.22 billion | $1.12 billion |
| Revenue (TTM) | $397.41 million | $357.28 million |
| Net Income (TTM) | $37.71 million | $-19,415,000 |
BLLN leads on 3 of 3 size & scale factors.
Valuation
| BLLN | CSTL | |
|---|---|---|
| P/E Ratio | 102.83 | — |
| Price / Book | 9.73 | 2.39 |
| Price / Sales | 13.14 | 3.14 |
CSTL leads on 2 of 2 valuation factors.
Profitability
| BLLN | CSTL | |
|---|---|---|
| Net Margin | 9.49% | -5.43% |
| Return on Equity | 7.03% | -4.13% |
BLLN leads on 2 of 2 profitability factors.
Risk & Sentiment
| BLLN | CSTL | |
|---|---|---|
| Short Interest | 0.12% | 0.04% |
CSTL leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLLN overview, BLLN financials, CSTL overview, CSTL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.